Opportunity Information: Apply for CDC RFA GH13 134302CONT14
Apply for CDC RFA GH13 134302CONT14
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthen Brazils National Response to HIV and Other Diseases Through Innovative and Evidence Based Approaches in Laboratory, Strategic Information, Prevention and Care Activities and Foster Partnerships Between Brazil, Angola and Mozambique under t" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Mar 2, 2014 and posted on Mar 2, 2014.
- Applicants must submit their applications by Apr 1, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- This award will be a continuation of funds intended only for grantees previously awarded under Funding Opportunity Number GH13 1343, Strengthen Brazils National Response to HIV and Other Diseases Through Innovative and Evidence Based Approaches in Laboratory, Strategic Information, Prevention and Care Activities and Foster Partnerships Between Brazil, Angola and Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, issued by the Centers for Disease Control and Prevention (CDC) under the President's Emergency Plan for AIDS Relief (PEPFAR), focuses on strengthening Brazil's national response to HIV and other diseases by supporting innovative and evidence-based approaches across several core public health areas. The announcement emphasizes work in laboratory systems, strategic information, prevention, and care and treatment activities, with an added goal of fostering partnerships and technical collaboration between Brazil and two Portuguese-speaking African countries, Angola and Mozambique. In practical terms, the grant is designed to reinforce the systems and programs that allow a country to detect HIV and related conditions earlier, monitor the epidemic more accurately, deliver prevention services more effectively, and improve the quality and continuity of clinical care for people living with HIV, while also promoting cross-country learning and capacity building within the broader Lusophone network.
The award mechanism is a cooperative agreement, which generally means the CDC expects to have substantial involvement in the funded work beyond simply providing money. Cooperative agreements typically involve close collaboration on program strategy, technical guidance, performance monitoring, and alignment with national and PEPFAR priorities. The activity category is health, and the CFDA number listed is 93.067 (Global AIDS), indicating the work sits within the U.S. government global HIV/AIDS portfolio. Only one award was expected under this continuation notice, and the estimated total funding is listed as 0 in the notice, which can occur in continuation or administrative postings where the specific dollar amount is handled through internal budgeting actions rather than displayed as a new, competed pot of funding.
A key point is that this is not an open, competitive grant for new applicants. The opportunity category is marked as "Continuation," and eligibility is restricted to organizations that were previously funded under the original funding opportunity number GH13-1343, which carried the same project title and focus. In other words, the intent is to extend or continue an existing project or program already underway rather than start a new one with a different recipient. The eligible applicant field is listed as "Others (see text field...)," but the eligibility clarification makes it clear the continuation funds are intended only for prior grantees under the specified original announcement. The posting date and creation date are both March 2, 2014, with an original and current closing date of April 1, 2014, and an archive date of May 1, 2014, reflecting the administrative window for processing the continuation action.
From a program content standpoint, the title lays out four major technical pillars. First, laboratory strengthening typically includes improving diagnostic capacity, quality assurance systems, specimen transport networks, and the reliability and timeliness of test results, which are foundational for HIV diagnosis, viral load monitoring, early infant diagnosis, and detection of co-infections or other relevant diseases. Second, "strategic information" usually refers to the data systems and analytics used to understand the epidemic and track program performance, such as surveillance, monitoring and evaluation, data quality improvement, routine reporting, and using data for decision-making at national and subnational levels. Third, prevention activities often involve evidence-based interventions tailored to populations at higher risk, strengthening outreach and linkage services, and integrating prevention with testing and other services. Fourth, care activities generally cover improving access to and quality of HIV clinical services, retention in care, treatment adherence support, clinical monitoring, and potentially integration with services for tuberculosis, sexually transmitted infections, hepatitis, or other comorbidities, depending on national priorities and the scope of the ongoing project.
The partnership component involving Brazil, Angola, and Mozambique signals an emphasis on South-to-South collaboration and shared language and health system context. The intent is typically to leverage Brazil's public health experience and technical capacity, while supporting mutual learning and strengthening institutional ties that can improve HIV program implementation in all participating countries. Such partnerships can include technical exchanges, joint trainings, harmonization of guidelines or tools where appropriate, mentorship arrangements between laboratories or surveillance units, and collaborative approaches to implementing proven interventions.
Administrative details included in the notice specify there is no cost sharing or matching requirement, meaning the recipient is not required to contribute a set amount of non-federal funds to receive the award. For applicants (in this case, the existing grantee) needing assistance accessing the full announcement, the CDC provides a contact point through CDC/PGO, with a phone number (770-488-2700) and email (pgotim@cdc.gov). Overall, the opportunity represents a continuation action under PEPFAR meant to sustain and deepen an existing CDC-supported effort to strengthen Brazil's HIV and related disease response while building collaborative bridges with Angola and Mozambique through proven, data-driven public health approaches.
FAQs: CDC PEPFAR Cooperative Agreement (Continuation) - Brazil HIV and Related Diseases
What is this funding opportunity about?
This CDC funding opportunity under the President's Emergency Plan for AIDS Relief (PEPFAR) supports efforts to strengthen Brazil's national response to HIV and other related diseases. The work emphasizes innovative, evidence-based approaches across laboratory systems, strategic information, prevention, and care and treatment, while also encouraging technical collaboration with Angola and Mozambique.
Which agency is offering this opportunity?
The opportunity is issued by the Centers for Disease Control and Prevention (CDC).
What is PEPFAR's role in this opportunity?
The opportunity sits within PEPFAR, the U.S. government initiative supporting the global HIV/AIDS response. The focus areas described align with strengthening national systems for HIV detection, monitoring, prevention services, and continuity of clinical care.
What type of award is being used?
The award mechanism is a cooperative agreement.
What does a cooperative agreement mean in practice?
A cooperative agreement generally means CDC expects substantial involvement in the funded work beyond providing funds. This can include close collaboration on program strategy, technical guidance, performance monitoring, and alignment with national priorities and PEPFAR priorities.
Is this a competitive grant open to new applicants?
No. The opportunity category is listed as "Continuation," and it is not an open competition for new applicants.
Who is eligible to apply for this continuation?
Eligibility is restricted to organizations that were previously funded under the original funding opportunity number GH13-1343 (the original announcement with the same project title and focus). The continuation is intended to extend or continue an existing project rather than fund a new recipient.
What is the original funding opportunity number referenced for eligibility?
The eligibility restriction references the original funding opportunity number GH13-1343.
How many awards were expected under this notice?
Only one award was expected under this continuation notice.
What is the activity category for this opportunity?
The activity category is health.
What is the CFDA number for this opportunity, and what does it indicate?
The CFDA number listed is 93.067 (Global AIDS). This indicates the work is part of the U.S. government global HIV/AIDS portfolio.
How much funding is available?
The estimated total funding is listed as 0 in the notice. This can occur in continuation or administrative postings where the specific dollar amount is handled through internal budgeting actions rather than shown as a newly competed funding amount.
Does this opportunity require cost sharing or matching funds?
No. The notice specifies there is no cost sharing or matching requirement.
What are the main technical focus areas (pillars) of the work?
The title and program description emphasize four major pillars: laboratory strengthening, strategic information, prevention, and care and treatment activities.
What kinds of activities are included under laboratory strengthening?
Laboratory strengthening typically includes improving diagnostic capacity, quality assurance systems, specimen transport networks, and the reliability and timeliness of test results. These capabilities support HIV diagnosis, viral load monitoring, early infant diagnosis, and detection of co-infections or other relevant diseases.
What does "strategic information" mean in this context?
"Strategic information" generally refers to the data systems and analytics used to understand the epidemic and track program performance. This can include surveillance, monitoring and evaluation, data quality improvement, routine reporting, and using data for decision-making at national and subnational levels.
What types of prevention work are emphasized?
Prevention activities often involve evidence-based interventions tailored to populations at higher risk, strengthening outreach and linkage services, and integrating prevention with testing and other services.
What types of care and treatment work are emphasized?
Care activities generally focus on improving access to and quality of HIV clinical services, retention in care, treatment adherence support, and clinical monitoring. The description also notes that integration with services for tuberculosis, sexually transmitted infections, hepatitis, or other comorbidities may be part of the scope depending on national priorities and the ongoing project.
What is the purpose of the partnership component involving Angola and Mozambique?
The opportunity includes an added goal of fostering partnerships and technical collaboration between Brazil and two Portuguese-speaking African countries, Angola and Mozambique. This signals an emphasis on South-to-South collaboration, cross-country learning, and capacity building within the Lusophone network.
What kinds of Brazil-Angola-Mozambique collaboration might be supported?
Examples described include technical exchanges, joint trainings, harmonization of guidelines or tools where appropriate, mentorship arrangements between laboratories or surveillance units, and collaborative approaches to implementing proven interventions.
What are the key dates listed in the notice?
The posting date and creation date are both March 2, 2014. The original and current closing date is April 1, 2014, and the archive date is May 1, 2014.
Why might a continuation notice have a short administrative window?
The listed closing and archive dates reflect the administrative window for processing the continuation action, rather than a typical open application period for new applicants.
Who can be contacted for help accessing the full announcement?
The notice lists CDC/PGO as the contact point for assistance, with phone number 770-488-2700 and email pgotim@cdc.gov.
Browse more opportunities from the same category: Health
Next opportunity: Strengthening the Capacity of the Republican AIDS Center to Implement HIV Programs in the Kyrgyz Republic under the Presidents Emergency Plan for AIDS Relief
Previous opportunity: NATIONAL ASSOCIATION FOR PUBLIC HEALTH STATISTICS AND INFORMATION SYSTEMS (NAPHSIS)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 134302CONT14
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 134302CONT14) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening the Capacity of the Republican AIDS Center to Implement HIV Programs in the Kyrgyz Republic under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA PS10 1016306CONT14 Funding Number: CDC RFA PS10 1016306CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening the Capacity of the Republican AIDS Center to Implement HIV Programs in the Republic of Tajikistan under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA PS10 1016505CONT14 Funding Number: CDC RFA PS10 1016505CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening the Capacity of the Republican AIDS Center to Implement HIV Programs in the Republic of Kazakhstan under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA PS10 1016405CONT14 Funding Number: CDC RFA PS10 1016405CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening and Enhancing National HIV/AIDS Prevention, Diagnosis, Care, Treatment, Monitoring and Surveillance within the Ministry of Health (MOH) in the Republic of Haiti Apply for CDC RFA PS10 100905CONT14 Funding Number: CDC RFA PS10 100905CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Expanding Coverage and Improving the Quality of Facility and Community Based Prevention of Mother to Child Transmission of HIV Programs in Two Regions of Cameroon under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 115304CONT14 Funding Number: CDC RFA GH11 115304CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Neuroimmune Mechanisms of Alcohol Related Disorders (R21) Apply for PA 14 138 Funding Number: PA 14 138 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Neuroimmune Mechanisms of Alcohol Related Disorders (R01) Apply for PA 14 139 Funding Number: PA 14 139 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Early Intervention Services (EIS Program) Service Area Competition Additional Service Area Ponce, Puerto Rico Apply for HRSA 14 135 Funding Number: HRSA 14 135 Agency: Health Resources and Services Administration Category: Health Funding Amount: $1,200,000 |
| Affordable Care Act Maternal, Infant, and Early Childhood Home Visiting Program Nonprofit Organizations Competition Apply for HRSA 14 101 Funding Number: HRSA 14 101 Agency: Health Resources and Services Administration Category: Health Funding Amount: $3,162,393 |
| Zambia Midterm Evaluation Reports Apply for USAID ZAMBIA 611 INFORMATION 03 2014 Funding Number: USAID ZAMBIA 611 INFORMATION 03 2014 Agency: Zambia USAID Lusaka Category: Health Funding Amount: Case Dependent |
| Strengthening HIV/AIDS Prevention, Care and Treatment Referral Services to Apply for CDC RFA GH11 119204CONT14 Funding Number: CDC RFA GH11 119204CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Development of a Laboratory Network and Society to Implement a Quality Systems Improvement Program Toward Accreditation and Laboratory Management under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 120103CONT14 Funding Number: CDC RFA GH12 120103CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Caribbean Regional Epidemiology and Laboratory Training Program (RELTP) under the Presidents Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 120603CONT14 Funding Number: CDC RFA GH12 120603CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Addressing Emerging Infectious Diseases and the International Health Regulations Apply for CDC RFA CK14 1402 Funding Number: CDC RFA CK14 1402 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Establishing Behavioral and Social Measures for Causal Pathway Research in Dental, Oral and Craniofacial Health (R01) Apply for PAR 14 143 Funding Number: PAR 14 143 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Establishing Behavioral and Social Measures for Causal Pathway Research in Dental, Oral and Craniofacial Health (R21) Apply for PAR 14 144 Funding Number: PAR 14 144 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIBIB Biomedical Technology Service Centers (P30) Apply for PAR 14 145 Funding Number: PAR 14 145 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| Genomes to Natural Products (U01) Apply for RFA GM 15 001 Funding Number: RFA GM 15 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support (NAM PHACTS) under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 1415 Funding Number: CDC RFA GH14 1415 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $7,600,000 |
| Planning Grants for Alzheimers Disease Translational Centers for Predictive Drug Development (R34) Apply for RFA AG 14 017 Funding Number: RFA AG 14 017 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 134302CONT14", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
